The stock performance of most companies with ASCO news is summarized below. Biotechnology stocks are driven by clinical and deal news so here are some trends to consider:

• Anticipation of positive news from ASCO drove gains before the Meeting. The rally began in late May just after Abstracts were released.The XBI is up 4.9% over the past month.
• Stocks usually sell-off after the news but consider which stocks can hold near their highs.
• Individual stocks with notable news were very strong and the overall sector is still up this week.Big winners were BLUE, CLVS, KITE LOXO and PUMA.
• CAR-T stocks bluebird bio (BLUE) and Kite Pharma (KITE) were huge winners.
• The biotech sector is outperforming the market in 2017 up 18-21% YTD.

In our next review of ASCO related stocks we will look through the data to identify breakthrough product potential and upgrades.